Home > Insider Trading > Filing (0001371285-21-000261)

Filing Details

Accession Number:: 0001371285-21-000261
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-10-04 21:58:23
Reporting Period:: 2021-09-30

Accepted Time:: 2021-10-04 21:58:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371285	Trupanion Inc.	TRUP	Hospital & Medical Service Plans (6324)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673762	Tricia Plouf	C/O Trupanion, Inc. 6100 4Th Avenue South, Suite 200 Seattle WA 98108	Co-President And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-30	2,256	$7.78	33,081	No	4	M	Direct
Common Stock	Disposition	2021-09-30	827	$78.68	32,254	No	4	S	Direct
Common Stock	Disposition	2021-09-30	739	$80.07	31,515	No	4	S	Direct
Common Stock	Disposition	2021-09-30	690	$80.94	30,825	No	4	S	Direct
Common Stock	Disposition	2021-09-30	539	$78.65	30,286	No	4	S	Direct
Common Stock	Disposition	2021-09-30	600	$80.51	29,686	No	4	S	Direct
Common Stock	Disposition	2021-09-30	105	$81.51	29,581	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-09-30	2,256	$0.00	2,256	$7.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,999		2025-07-24	No	4	M	Direct

Footnotes

The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 27, 2020 and amended on November 30, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.49 to $79.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.49 to $80.39 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.55 to $81.51 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.49 to $78.84 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.39 to $80.76 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is fully vested.